Could a pill stop snake venom? new trial tests oral drugs against antivenom
NCT ID NCT07500233
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial tests two oral drugs, DMPS and marimastat, to see if they can reduce the harmful effects of snake venom. 504 adults in Brazil and Ghana who have been bitten by a snake will receive either the drug, a placebo, or standard antivenom. The goal is to find a treatment that can be given quickly in rural clinics, potentially saving lives and preventing disability.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DMPS (unithiol) and marimastat, taken orally
What this could lead to
If successful, these oral drugs could be given sooner than antivenom, potentially reducing disability and death from snakebites, especially in remote areas.
What could go wrong
This is an early phase 2 trial with only 504 participants. The drugs may not work as hoped, could have side effects, or may not be as effective as antivenom.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SNAKEBITE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••